Correlations between angiogenic factors and capillaroscopic patterns in systemic sclerosis

Arthritis Research and Therapy

Volumn 15, Issue 2, 2013, Pages

  Avouac, Jérôme ^a,b   Vallucci, Maeva ^b   Smith, Vanessa ^c   Senet, Patricia ^d   Ruiz, Barbara ^b   Sulli, Alberto ^e   Pizzorni, Carmen ^e   Frances, Camille ^d   Chiocchia, Gilles ^b   Cutolo, Maurizio ^e   Allanore, Yannick ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSTITUT COCHIN   (France)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d UNIVERSITÉ PARIS OUEST NANTERRE LA DÉFENSE   (France)

^e UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; BIOLOGICAL MARKER; CALCIUM CHANNEL BLOCKING AGENT; CD133 ANTIGEN; CD34 ANTIBODY; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOGLIN; ENDOSTATIN; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; PLACENTAL GROWTH FACTOR; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CAPILLAROSCOPY; CELL COUNT; CIRCULATING ENDOTHELIAL CELL; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; FEMALE; FINGER ULCER; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NAILFOLD VIDEOCAPILLAROSCOPY; PROTEIN BLOOD LEVEL; SYSTEMIC SCLEROSIS; ANGIOSCOPY; BLOOD; COHORT ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; MIDDLE AGED; NAIL; PATHOLOGY; PROCEDURES; STEM CELL; VASCULARIZATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COHORT STUDIES; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MICROSCOPIC ANGIOSCOPY; MIDDLE AGED; NAILS; SCLERODERMA, SYSTEMIC; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84876285772     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4217     Document Type: Article

References (42)

1. Allanore Y, Avouac J, Wipff J, Kahan A. New therapeutic strategies in the management of systemic sclerosis. Expert Opin Pharmacother 2007, 8:607-615. 10.1517/14656566.8.5.607, 17376016.
2. Sgonc R, Gruschwitz MS, Dietrich H, Recheis H, Gershwin ME, Wick G. Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma. J Clin Invest 1996, 98:785-792. 10.1172/JCI118851, 507489, 8698871.
3. Maurer B, Busch N, Jungel A, Pileckyte M, Gay RE, Michel BA, Schett G, Gay S, Distler J, Distler O. Transcription factor fos-related antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis. Circulation 2009, 120:2367-2376. 10.1161/CIRCULATIONAHA.109.855114, 19933934.
4. Reich N, Maurer B, Akhmetshina A, Venalis P, Dees C, Zerr P, Palumbo K, Zwerina J, Nevskaya T, Gay S, Distler O, Schett G, Distler JH. The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis. Arthritis Rheum 2010, 62:280-290. 10.1002/art.25056, 20039427.
5. Nguyen VA, Sgonc R, Dietrich H, Wick G. Endothelial injury in internal organs of University of California at Davis line 200 (UCD 200) chickens, an animal model for systemic sclerosis (scleroderma). J Autoimmun 2000, 14:143-149. 10.1006/jaut.1999.0355, 10677245.
6. Avouac J, Elhai M, Allanore Y. Experimental models of dermal fibrosis and systemic sclerosis. Joint Bone Spine 2013, 80:23-28. 10.1016/j.jbspin.2012.06.005, 22841579.
7. Fleming JN, Nash RA, McLeod DO, Fiorentino DF, Shulman HM, Connolly MK, Molitor JA, Henstorf G, Lafyatis R, Pritchard DK, Adams LD, Furst DE, Schwartz SM. Capillary regeneration in scleroderma: stem cell therapy reverses phenotype?. PLoS ONE 2008, 3:e1452. 10.1371/journal.pone.0001452, 2175530, 18197262.
8. Cutolo M, Sulli A, Pizzorni C, Accardo S. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000, 27:155-160.
9. Cutolo M, Sulli A, Smith V. Evaluating microangiopathy in systemic sclerosis: what have we learnt and what is left to discover?. Expert Rev Clin Immunol 2011, 7:395-397. 10.1586/eci.11.35, 21790279.
10. Avouac J, Fransen J, Walker UA, Riccieri V, Smith V, Muller C, Miniati I, Tarner IH, Randone SB, Cutolo M, Allanore Y, Distler O, Valentini G, Czirjak L, Müller-Ladner U, Furst DE, Tyndall A, Matucci-Cerinic M,. EUSTAR Group Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis 2011, 70:476-481. 10.1136/ard.2010.136929, 21081523, EUSTAR Group.
11. Allanore Y, Borderie D, Lemarechal H, Ekindjian OG, Kahan A. Nifedipine decreases sVCAM-1 concentrations and oxidative stress in systemic sclerosis but does not affect the concentrations of vascular endothelial growth factor or its soluble receptor 1. Arthritis Res Ther 2004, 6:R309-R314. 10.1186/ar1183, 464873, 15225366.
12. Distler O, Del Rosso A, Giacomelli R, Cipriani P, Conforti ML, Guiducci S, Gay RE, Michel BA, Brühlmann P, Müller-Ladner U, Gay S, Matucci-Cerinic M. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Arthritis Res 2002, 4:R11. 10.1186/ar596, 153841, 12453314.
13. Wipff J, Avouac J, Borderie D, Zerkak D, Lemarechal H, Kahan A, Boileau C, Allanore Y. Disturbed angiogenesis in systemic sclerosis: high levels of soluble endoglin. Rheumatology (Oxford) 2008, 47:972-975.
14. Hummers LK, Hall A, Wigley FM, Simons M. Abnormalities in the regulators of angiogenesis in patients with scleroderma. J Rheumatol 2009, 36:576-582. 10.3899/jrheum.080516, 19228661.
15. Avouac J, Juin F, Wipff J, Couraud PO, Chiocchia G, Kahan A, Boileau C, Uzan G, Allanore Y. Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity. Ann Rheum Dis 2008, 67:1455-1460. 10.1136/ard.2007.082131, 18174219.
16. Avouac J, Uzan G, Kahan A, Boileau C, Allanore Y. Endothelial progenitor cells and rheumatic disorders. Joint Bone Spine 2008, 75:131-137. 10.1016/j.jbspin.2007.09.006, 18314371.
17. Riccieri V, Stefanantoni K, Vasile M, Macri V, Sciarra I, Iannace N, Alessandri C, Valesini G. Abnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis. Clin Exp Rheumatol 2011, 29:S46-S52.
18. Avouac J, Meune C, Ruiz B, Couraud PO, Uzan G, Boileau C, Kahan A, Chiocchia G, Allanore Y. Angiogenic biomarkers predict the occurrence of digital ulcers in systemic sclerosis. Ann Rheum Dis 2012, 71:394-399. 10.1136/annrheumdis-2011-200143, 22085793.
19. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Bull Rheum Dis 1981, 31:1-6.
20. Clements PJ, Lachenbruch PA, Ng SC, Simmons M, Sterz M, Furst DE. Skin score: a semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis. Arthritis Rheum 1990, 33:1256-1263.
21. Allanore Y, Borderie D, Avouac J, Zerkak D, Meune C, Hachulla E, Mouthon L, Guillevin L, Meyer O, Ekindjian OG, Weber S, Kahan A. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis. Arthritis Rheum 2008, 58:284-291. 10.1002/art.23187, 18163505.
22. Avouac J, Airò P, Meune C, Beretta L, Dieude P, Caramaschi P, Tiev K, Cappelli S, Diot E, Vacca A, Cracowski JL, Sibilia J, Kahan A, Matucci-Cerinic M, Allanore Y. Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies. J Rheumatol 2010, 37:2290-2298. 10.3899/jrheum.100245, 20810505.
23. Cutolo M, Nobili F, Sulli A, Pizzorni C, Briata M, Faelli F, Vitali P, Mariani G, Copello F, Seriolo B, Barone C, Rodriguez G. Evidence of cerebral hypoperfusion in scleroderma patients. Rheumatology (Oxford) 2000, 39:1366-1373.
24. Sulli A, Secchi ME, Pizzorni C, Cutolo M. Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients. Ann Rheum Dis 2008, 67:885-887. 10.1136/ard.2007.079756, 18037628.
25. Khan SS, Solomon MA, McCoy JP. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry B Clin Cytom 2005, 64:1-8.
26. Dziankowska-Bartkowiak B, Waszczykowska E, Dziankowska-Zaboroszczyk E, de Graft-Johnson JE, Zalewska A, Luczynska M, Nowak D. Decreased ratio of circulatory vascular endothelial growth factor to endostatin in patients with systemic sclerosis: association with pulmonary involvement. Clin Exp Rheumatol 2006, 24:508-513.
27. Coral-Alvarado P, Quintana G, Garces MF, Cepeda LA, Caminos JE, Rondon F, Iglesias-Gamarra A, Restrepo JF. Potential biomarkers for detecting pulmonary arterial hypertension in patients with systemic sclerosis. Rheumatol Int 2009, 29:1017-1024. 10.1007/s00296-008-0829-8, 19116719.
28. Noda S, Asano Y, Aozasa N, Akamata K, Yamada D, Masui Y, Tamaki Z, Kadono T, Sato S. Serum Tie2 levels: clinical association with microangiopathies in patients with systemic sclerosis. J Eur Acad Dermatol Venereol 2011, 25:1476-1479. 10.1111/j.1468-3083.2011.04012.x, 21366713.
29. Jodon de Villeroche V, Avouac J, Ponceau A, Ruiz B, Kahan A, Boileau C, Uzan G, Allanore Y. Enhanced late-outgrowth circulating endothelial progenitor cell levels in rheumatoid arthritis and correlation with disease activity. Arthritis Res Ther 2010, 12:R27. 10.1186/ar2934, 2875661, 20158894.
30. Del Papa N, Quirici N, Soligo D, Scavullo C, Cortiana M, Borsotti C, Maglione W, Comina DP, Vitali C, Fraticelli P, Gabrielli A, Cortelezzi A, Lambertenghi-Deliliers G. Bone marrow endothelial progenitors are defective in systemic sclerosis. Arthritis Rheum 2006, 54:2605-2615. 10.1002/art.22035, 16868984.
31. Del Papa N, Colombo G, Fracchiolla N, Moronetti LM, Ingegnoli F, Maglione W, Comina DP, Vitali C, Fantini F, Cortelezzi A. Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis. Arthritis Rheum 2004, 50:1296-1304. 10.1002/art.20116, 15077314.
32. Koch AE, Distler O. Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis. Arthritis Res Ther 2007, 9(Suppl 2):S3. 10.1186/ar2187, 2072889, 17767741.
33. Huang CL, Mutasim DF. Sarcoidosis mimicking lipodermatosclerosis. Cutis 2005, 75:322-324.
34. Kuwana M. Potential benefit of statins for vascular disease in systemic sclerosis. Curr Opin Rheumatol 2006, 18:594-600. 10.1097/01.bor.0000245720.02512.3e, 17053504.
35. Ferri C, Giuggioli D, Sebastiani M, Colaci M. Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin. Clin Exp Dermatol 2007, 32:287-290. 10.1111/j.1365-2230.2007.02363.x, 17397351.
36. Choi JJ, Min DJ, Cho ML, Min SY, Kim SJ, Lee SS, Park KS, Seo YI, Kim WU, Park SH, Cho CS. Elevated vascular endothelial growth factor in systemic sclerosis. J Rheumatol 2003, 30:1529-1533.
37. Moneib HA, Salem SA, Aly DG, Khedr HT, Wafaey HA, Hassan HE. Assessment of serum vascular endothelial growth factor and nail fold capillaroscopy changes in systemic lupus erythematosus with and without cutaneous manifestations. J Dermatol 2012, 39:52-57. 10.1111/j.1346-8138.2011.01322.x, 21950586.
38. Distler O, Distler JH, Scheid A, Acker T, Hirth A, Rethage J, Michel BA, Gay RE, Müller-Ladner U, Matucci-Cerinic M, Plate KH, Gassmann M, Gay S. Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis. Circ Res 2004, 95:109-116. 10.1161/01.RES.0000134644.89917.96, 15178641.
39. Caramaschi P, Canestrini S, Martinelli N, Volpe A, Pieropan S, Ferrari M, Bambara LM, Carletto A, Biasi D. Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity. Rheumatology (Oxford) 2007, 46:1566-1569.
40. Sebastiani M, Manfredi A, Colaci M, D'Amico R, Malagoli V, Giuggioli D, Ferri C. Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. Arthritis Rheum 2009, 61:688-694. 10.1002/art.24394, 19405007.
41. Sebastiani M, Manfredi A, Vukatana G, Moscatelli S, Riato L, Bocci M, Iudici M, Principato A, Mazzuca S, Del Medico P, De Angelis R, D'Amico R, Vicini R, Colaci M, Ferri C. Predictive role of capillaroscopic skin ulcer risk index in systemic sclerosis: a multicentre validation study. Ann Rheum Dis 2012, 71:67-70. 10.1136/annrheumdis-2011-200022, 21917823.
42. Smith V, De Keyser F, Pizzorni C, Van Praet JT, Decuman S, Sulli A, Deschepper E, Cutolo M. Nailfold capillaroscopy for day-to-day clinical use: construction of a simple scoring modality as a clinical prognostic index for digital trophic lesions. Ann Rheum Dis 2011, 70:180-183. 10.1136/ard.2010.132431, 20971717.